Kozak & Associates’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.01K Hold
64
﹤0.01% 308
2026
Q1
$4.31K Hold
64
﹤0.01% 328
2025
Q4
$5.51K Hold
64
﹤0.01% 300
2025
Q3
$4.88K Hold
64
﹤0.01% 312
2025
Q2
$4.75K Hold
64
﹤0.01% 294
2025
Q1
$4.34K Hold
64
﹤0.01% 304
2024
Q4
$4.3K Hold
64
﹤0.01% 303
2024
Q3
$4.57K Sell
64
-5
-7% -$301 ﹤0.01% 277
2024
Q2
$3.51K Hold
69
﹤0.01% 287
2024
Q1
$4.25K Buy
+69
New +$5.17K ﹤0.01% 286

Other funds holding SOLV

Kozak & Associates's SOLV Position: Q2 2026 in Review

Kozak & Associates held its Solventum (SOLV) position steady in Q2 2026 at 64 shares worth $5.01K. The position accounts for ﹤0.01% of the portfolio, ranked #308.

Kozak & Associates first reported a position in SOLV in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.51K in Q4 2025. 875 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Kozak & Associates held 64 shares of Solventum worth $5.01K as of Q2 2026.
  • Kozak & Associates left its Solventum share count unchanged in Q2 2026.
  • Solventum made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #308 holding.
  • Kozak & Associates first reported a position in Solventum in Q1 2024 and has held it in 10 quarters since.
  • Kozak & Associates's Solventum position peaked at $5.51K in Q4 2025.
  • 875 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.